ALAFY.PA
AFYREN SAS [ALAFY.PA] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ALAFY.PA Stock Summary
Top 10 Correlated ETFs
ALAFY.PA
Top 10 Correlated Stocks
ALAFY.PA
In the News
ALAFY.PA Financial details
Company Rating
Neutral
Market Cap
57.17M
Income
-18.79M
Revenue
6.84M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
120
Optionable
No
Shortable
Yes
Earnings
30 Sep 2024
P/E
-5.8
Forward P/E
-
PEG
-0.65
P/S
14.74
P/B
0.75
P/C
-
P/FCF
-13.31
Quick Ratio
7.84
Current Ratio
8.02
Debt / Equity
0.07
LT Debt / Equity
0.05
-
-
EPS (TTM)
-0.68
EPS next Y
-
EPS next Q
-
EPS this Y
-27.78%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
30.31%
Revenue last 5Y
7.83%
Revenue Q/Q
-27.25%
EPS Q/Q
-40%
-
-
-
-
SMA20
43.33%
SMA50
5.91%
SMA100
-27.36%
Inst Own
-
Inst Trans
-
ROA
-11%
ROE
-12%
ROC
-0.07%
Gross Margin
31%
Oper. Margin
-155%
Profit Margin
-266%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.405-5.8
52W High
-56%
52W Low
+120%
RSI
59.42
Rel Volume
0.78
Avg Volume
32.99K
Volume
25.79K
Perf Week
11.11%
Perf Month
36.65%
Perf Quarter
-40.05%
Perf Half Y
-44.16%
-
-
-
-
Beta
0.266
-
-
Volatility
0.21%, 0.3%
Prev Close
-2.65%
Price
2.2
Change
-10.2%
ALAFY.PA Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.09 | 0.15 | 0.12 | 0.13 | 0 | |
| Net income per share | -0.07 | -0.08 | -0.14 | -0.36 | 0 | |
| Operating cash flow per share | -0.03 | -0.02 | -0.11 | -0.13 | 0 | |
| Free cash flow per share | -0.04 | -0.03 | -0.12 | -0.15 | 0 | |
| Cash per share | 0.07 | 0.37 | 2.61 | 2.42 | 0 | |
| Book value per share | 0.21 | 0.76 | 3.02 | 2.75 | 0 | |
| Tangible book value per share | 0.06 | 0.61 | 2.88 | 2.61 | 0 | |
| Share holders equity per share | 0.21 | 0.76 | 3.02 | 2.75 | 0 | |
| Interest debt per share | 0.11 | 0.38 | 0.36 | 0.34 | 0 | |
| Market cap | 198.37M | 198.37M | 223.61M | 149.46M | 0 | |
| Enterprise value | 199.46M | 198.26M | 165.44M | 95.67M | -44.77M | |
| P/E ratio | -111.19 | -93 | -61.96 | -16.25 | 0 | |
| Price to sales ratio | 85.58 | 49.7 | 73.65 | 43.25 | 0 | |
| POCF ratio | -267.7 | -512.58 | -82.36 | -45.35 | 0 | |
| PFCF ratio | -183.84 | -227.49 | -73.08 | -39.05 | 0 | |
| P/B Ratio | 35.99 | 10.13 | 2.87 | 2.11 | 0 | |
| PTB ratio | 35.99 | 10.13 | 2.87 | 2.11 | 0 | |
| EV to sales | 86.05 | 49.68 | 54.49 | 27.68 | -13.25 | |
| Enterprise value over EBITDA | -168.04 | -165.35 | -56.89 | -11.34 | 8.75 | |
| EV to operating cash flow | -269.18 | -512.3 | -60.93 | -29.02 | 11.51 | |
| EV to free cash flow | -184.86 | -227.36 | -54.06 | -25 | 9.26 | |
| Earnings yield | -0.01 | -0.01 | -0.02 | -0.06 | 0 | |
| Free cash flow yield | -0.01 | 0 | -0.01 | -0.03 | 0 | |
| Debt to equity | 0.52 | 0.48 | 0.11 | 0.12 | 0.07 | |
| Debt to assets | 0.18 | 0.26 | 0.1 | 0.1 | 0.06 | |
| Net debt to EBITDA | -0.92 | 0.09 | 20.01 | 6.38 | 8.75 | |
| Current ratio | 1.13 | 1.84 | 19.27 | 8.02 | 11.54 | |
| Interest coverage | -4.66 | 0.42 | -10.07 | -26.99 | -19.96 | |
| Income quality | 0.42 | 0.18 | 0.75 | 0.36 | 0.41 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.25 | 0.11 | 0.04 | 0.04 | 0 | |
| Capex to operating cash flow | 0.46 | 1.25 | 0.13 | 0.16 | 0.24 | |
| Capex to revenue | -0.15 | -0.12 | -0.11 | -0.15 | -0.28 | |
| Capex to depreciation | -0.64 | -0.88 | -0.56 | -0.84 | -1.16 | |
| Stock based compensation to revenue | 0.03 | 0.05 | 0.11 | 0.7 | 0 | |
| Graham number | 0.58 | 1.19 | 3.09 | 4.7 | 0 | |
| ROIC | -0.01 | 0.01 | -0.02 | -0.04 | -0.18 | |
| Return on tangible assets | -0.15 | -0.07 | -0.04 | -0.11 | -0.14 | |
| Graham Net | -0.33 | -0.26 | 2.06 | 1.92 | 0 | |
| Working capital | 274K | 4.71M | 65.33M | 55.86M | 46.53M | |
| Tangible asset value | 1.55M | 15.61M | 74.1M | 67.36M | 62.76M | |
| Net current asset value | -8.01M | -6.01M | 53.61M | 49.98M | 43.28M | |
| Invested capital | 0.52 | 0.48 | 0.11 | 0.12 | 0.07 | |
| Average receivables | 73K | 237K | 712K | 990K | 675K | |
| Average payables | 227K | 102K | 329.5K | 516.5K | 454K | |
| Average inventory | 4.5K | 19K | 165.5K | 379K | 228K | |
| Days sales outstanding | 22.99 | 30 | 131.77 | 93.36 | 50.34 | |
| Days payables outstanding | 23.71 | 49.12 | 119.72 | 79.22 | 14.6 | |
| Days of inventory on hand | 3.68 | 9.76 | 70.48 | 69.47 | 0 | |
| Receivables turnover | 15.88 | 12.17 | 2.77 | 3.91 | 7.25 | |
| Payables turnover | 15.4 | 7.43 | 3.05 | 4.61 | 25.01 | |
| Inventory turnover | 99.22 | 37.41 | 5.18 | 5.25 | 0 | |
| ROE | -0.32 | -0.11 | -0.05 | -0.13 | -0.16 | |
| Capex per share | -0.01 | -0.02 | -0.01 | -0.02 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2021-12-31 | 2022-06-30 | 2022-12-31 | 2023-06-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0.07 | 0.07 | 0.08 | 0 | |
| Net income per share | 0 | -0.16 | -0.2 | -0.2 | 0 | |
| Operating cash flow per share | 0 | -0.07 | -0.06 | -0.07 | 0 | |
| Free cash flow per share | 0 | -0.08 | -0.08 | -0.08 | 0 | |
| Cash per share | 0 | 2.52 | 2.42 | 2.05 | 0 | |
| Book value per share | 0 | 2.9 | 2.75 | 2.55 | 0 | |
| Tangible book value per share | 0 | 2.76 | 2.61 | 2.41 | 0 | |
| Share holders equity per share | 0 | 2.9 | 2.75 | 2.55 | 0 | |
| Interest debt per share | 0 | 0.34 | 0.34 | 0.21 | 0 | |
| Market cap | 0 | 175.18M | 149.49M | 147.05M | 0 | |
| Enterprise value | -58.18M | 118.95M | 95.7M | 99.64M | -44.77M | |
| P/E ratio | 0 | -10.53 | -7.42 | -7.18 | 0 | |
| Price to sales ratio | 0 | 99.37 | 88.3 | 75.18 | 0 | |
| POCF ratio | 0 | -97.38 | -90.17 | -79.62 | 0 | |
| PFCF ratio | 0 | -86.98 | -73.97 | -68.27 | 0 | |
| P/B Ratio | 0 | 2.35 | 2.11 | 2.23 | 0 | |
| PTB ratio | 0 | 2.35 | 2.11 | 2.23 | 0 | |
| EV to sales | 0 | 67.47 | 56.53 | 50.94 | -31.46 | |
| Enterprise value over EBITDA | 0 | -47.32 | -35.6 | -34.16 | 13.53 | |
| EV to operating cash flow | 0 | -66.12 | -57.72 | -53.95 | 21.92 | |
| EV to free cash flow | 0 | -59.06 | -47.35 | -46.26 | 16.69 | |
| Earnings yield | 0 | -0.02 | -0.03 | -0.03 | 0 | |
| Free cash flow yield | 0 | -0.01 | -0.01 | -0.01 | 0 | |
| Debt to equity | 0.11 | 0.12 | 0.12 | 0.08 | 0.07 | |
| Debt to assets | 0.1 | 0.1 | 0.1 | 0.07 | 0.06 | |
| Net debt to EBITDA | 0 | 22.37 | 20.01 | 16.25 | 13.53 | |
| Current ratio | 19.27 | 9.01 | 8.02 | 10.68 | 11.54 | |
| Interest coverage | 0 | -27.6 | -30.78 | -23.08 | -24.3 | |
| Income quality | 0 | 0.43 | 0.33 | 0.36 | 0.46 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0.46 | 0 | |
| Intangibles to total assets | 0.04 | 0.04 | 0.04 | 0.05 | 0 | |
| Capex to operating cash flow | 0 | 0.12 | 0.22 | 0.17 | 0.31 | |
| Capex to revenue | 0 | -0.12 | -0.21 | -0.16 | -0.45 | |
| Capex to depreciation | 0 | -0.71 | -1.11 | -0.76 | -1.57 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0 | 3.25 | 3.48 | 3.37 | 0 | |
| ROIC | 0 | -0.05 | -0.07 | -0.09 | -0.11 | |
| Return on tangible assets | 0 | -0.05 | -0.06 | -0.07 | -0.06 | |
| Graham Net | 0 | 2 | 1.92 | 1.69 | 0 | |
| Working capital | 65.33M | 58.76M | 55.86M | 49.44M | 46.53M | |
| Tangible asset value | 74.1M | 71.09M | 67.36M | 62.43M | 62.76M | |
| Net current asset value | 53.61M | 51.91M | 49.98M | 44.09M | 43.28M | |
| Invested capital | 0.11 | 0.12 | 0.12 | 0.08 | 0.07 | |
| Average receivables | 0 | 293K | 735K | 1.1M | 895K | |
| Average payables | 552K | 470K | 473.5K | 504K | 438K | |
| Average inventory | 0 | 242K | 470K | 308.5K | 80.5K | |
| Days sales outstanding | 0 | 29.91 | 46.99 | 60.92 | 29.47 | |
| Days payables outstanding | 0 | 10.89 | 12.97 | 10.97 | 5.98 | |
| Days of inventory on hand | 0 | 12.35 | 11.38 | 3.62 | 0 | |
| Receivables turnover | 0 | 3.01 | 1.92 | 1.48 | 3.05 | |
| Payables turnover | 0 | 8.26 | 6.94 | 8.2 | 15.05 | |
| Inventory turnover | 0 | 7.29 | 7.91 | 24.86 | 0 | |
| ROE | 0 | -0.06 | -0.07 | -0.08 | -0.07 | |
| Capex per share | 0 | -0.01 | -0.01 | -0.01 | 0 |
ALAFY.PA Frequently Asked Questions
What is AFYREN SAS stock symbol ?
AFYREN SAS is a FR stock and trading under the symbol ALAFY.PA
What is AFYREN SAS stock quote today ?
AFYREN SAS stock price is $2.2 today.
Is AFYREN SAS stock public?
Yes, AFYREN SAS is a publicly traded company.
Company Profile
- Volume Average 32.99K
- Market Capitalization 57.17M
- Employee 120
- CEO Mr. Nicolas Sordet
- Headquarters Clermont-Ferrand,FR
- IPO Date 2021-10-01
-
Website
https://afyren.com 
AFYREN SAS, a sustainable chemical company, produces biomolecules derived from the recycling of non-food biomass, primarily used in human and animal nutrition, flavors and fragrances, life sciences, materials sciences, and lubricants sectors. It offers biosourced organic acids, such as acetic acid, propionic acid, butyric acid, isobutyric acid, valeric acid, isovaleric acid, and caproic acid. The company was incorporated in 2012 and is headquartered in Clermont-Ferrand, France.
